fective, and the production of a hyperchloremic acidosis is then necessary to restore responsiveness to a mercurial agent.' Ammonium chloride or calcium chloride, alone or in combination with the carbonic anhydrase inhibiter, acetazoleamide" 2 has been used successfully to produce a hyperchloremic acidosis in such subjects. Both salts have an unpleasant taste, however, and often are limited in their usefulness by severe gastrointestinal side effects. Experience in this laboratory now includes 2 instances of hematemesis associated with administration of calcium chloride. Since most patients with resistant edema have decreased liver function, due either to primary liver disease or to congestive liver disease secondary to long-standing heart failure, administration of ammonium chloride may produce ammonia toxicity. Many instances of this complication have been reported.3 4 Because of these undesirable side effects a search was instituted for a more satisfactory source of the chloride ion. At the suggestion of Dr GraplXJhic representation of the patient with congestitve heart deseribed treatment periods. L-lysine monohydrochloride was then administered in a dosage of 10 Gm. 4 times a day, usually in fruit juice immediately following a meal. No diuretic agents were adnministered during this period and no other changes were made in the therapeutic program. Following this preparatory period a daily injection of a mercurial diuretic was given, continuing the same dose of L-lysine monohydrochloride.
Urine volume and body weight were measured daily in all subjects throughout the study. Urine and plasma electrolyte concentrations and blood pH were frequently determined. The methods used for these determinations are described in a previous publication.1
Results Table 1 is a compilation of the clinical data, electrolyte changes, and response to therapy in each course during 3 phases of observation: (1) the control period preceding administration of L-lysine monohydrochloride; (2) the period of administration of L-lysine monohydrochloride during which hyperchloremic acidosis was produced; (3) the period during which l-lysine monohydrochloride and meralluride were administered together.
Circulation, Volume XXI, March 1960 Figure 1 is a graphic presentation of the results in a representative subject with cirrhosis of the liver.
Control Period
The ineffectiveness of the diuretics em ployed during this period is shown by the con stancy of body weight. Patients in whom weight loss is recorded during this period became unresponsive to the diuretics employed and had persistent edema. In patient R. H. calcium chloride was effective in restoring mercurial effect, but had to be discontinued because of nausea and vomiting, and li-lysine monohydroehloride was substituted. Figure 2 records this patient's course.
In those instances in which the initial urine chloride concentration is recorded above 10 mEq./L., a mercurial diuretic had been administered within the preceding 36 hours. In the setting of the hyperchloremic acidosis produced by the administration of L-lysine monohydrochloride, the administration of a mercurial agent was associated with a significant weight loss in all patients studied.
L-lysine monohydrochloride was continued to maintain the hyperchloremia during mercurial administration. The plasma chloride level returned toward normal during the diuresis. Potassium depletion was prevented by the administration of oral potassium chloride in amounts determined by the magnitude of the diuresis. Usually 3 to 6 Gm. of potassium chloride were sufficient.
In most instances the diuretic program was discontinued because a satisfactory clinical response had been produced. In some patients the therapeutic program became ineffective following an initial response, with significant edema or ascites still present. In several such patients the reestablishment of a hyperchloremic acidosis was associated with further mercurial diuretic response and further weight loss. This chloride salt has now been used in our clinical services for more than 2 years. L-lysine monohydrochloride proved to be acceptable to all patients studied. Cold fruit juice was found to be the most satisfactory vehicle for its administration, and the product was given immediately after a meal whenever possible. In no case was the medication refused-a not uncommon occurrence with both ammonium and calcium chloride. No side effects necessitating the discontinuance of L-lvsine monohydrochloride have occurred. There has been no instance of gastrointestinal bleeding associated with its administration.
Diarrhea was the only side effect noted, and it was never severe enough to require discontinuing the L-lysine monohydrochloride. In 1 instance diarrhea that had occurred in one course of treatment did not recur during a second.
Many of the patients had far advanced iimpairment of liver function at the time of study. In no instance was development of flapping tremor, mental chalnge, or other significant clinical deterioration noted as a result of L-lysine monohydrochloride administration.
Frequent urinalyses and blood urea and hematologic studies revealed no evidence of renal or hematopoietic toxicitv. Discussion L-lysine monohydrochloride is a salt of a naturally occurring amino acid with a molecular weight of 195 . It has been used in commercial food and vitamin preparations, and no human toxicity has been reported. In animnal studies, large amounts of l-lysine monohydrochloride, administered in a settinig of specific deficiency of other amino acids, have been associated with interference with optimal growth.6 7 The experimental conditions in these animal studies were extreme, and actually have no clinical counterpart in these studies. Five 
